Harlem Community Academic Partnership: Influenza Immunizations
哈莱姆社区学术合作伙伴:流感免疫接种
基本信息
- 批准号:8037097
- 负责人:
- 金额:$ 8.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-22 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdoptedAdultAreaAttitudeAvian InfluenzaAwarenessBehavioral Risk Factor Surveillance SystemCenters for Disease Control and Prevention (U.S.)ChildCitiesCommunitiesCommunity HealthDataDevelopmentDisadvantagedEducationElementsEquipment and supply inventoriesEvaluationGoalsGroup MeetingsHealthHealth PromotionHealth SurveysHealthy People 2010ImmunizationImmunization ProgramsInfluenzaInfluenza A Virus, H5N1 SubtypeInfluenza vaccinationInterceptInterventionJointsKnowledgeLearningMeasuresMethodsMinorityMissionMotivationMutateNeighborhoodsNew YorkNew York CityNursesNursing ServicesOnline SystemsOutcomePersonsPopulationPrincipal InvestigatorProcessProviderResearch InfrastructureResearch Project GrantsRoleServicesSiteSocial supportSourceStructureSurveysTestingTrustVaccinationVaccinesVisiting NurseWorkYellow Jacketsbasecommunity based participatory researchdesigndisorder preventionexperiencehigh riskimprovedinfluenza virus vaccineintervention programmeetingsnovel vaccinesoutreachpandemic diseasepost interventionprogramsracial and ethnic disparitiesresponsescale upsocialsocial health determinantsworking group
项目摘要
DESCRIPTION (provided by applicant): Proposed is a community based participatory research project (CBPR) and evaluation for improving influenza immunizations in high risk populations within disadvantaged minority communities. The Harlem Community and Academic Partnership (HCAP)'s Board includes residents, community based organizations, academic partners and the local health department who meet monthly to plan, conduct and review neighborhood assessments, interventions and evaluation activities; topic-specific issues are addressed through formation of Intervention Work Groups (IWGs). The HCAP Board noted especially low rates of influenza immunizations in Harlem and formed the VIVA (Venue Intensive Vaccine for Adults) IWG. This IWG has conducted separate pilots including a survey on barriers to immunization, development of culturally informed intervention materials, a pilot of "yellow jacket" outreach workers to engage and educate hard-to reach populations, and provision of immunizations at non-traditional sites. The goal of this proposal is to assemble these components to formally scale up and test the intervention for adults in the Harlem communities. To achieve these aims, the HCAP VIVA IWG will plan, organize and implement an intervention; our primary partner, Palladia Inc, provides outreach educators and a service network of over 120 CBOs to educate and mobilize the community for immunization as well as coordinate congregating persons with traditional and new non-traditional venues for immunizations; the local Visiting Nurse Service has agreed to provide nurses and influenza vaccines at the selected venues gratis. This program does not replace, but rather supplements existing vaccination programs in the city by adding more relevant education and new "non-traditional" venues. We expect that this program will increase rates of immunizations overall including the hard-to-reach populations. To evaluate this program, we will compare annual rates of immunization between Harlem and communities similar to Harlem in NYC, with data available by neighborhood through the NYC annual "Community Health Survey" (modified BRFSS from CDC) which includes 10,000 adult NYC residents. We will also conduct two cross sectional street intercept surveys (n=800) before and after each annual intervention program between harlem and comparison community residents. These data combined with yearly inventories of CBOs, will provide measures of barriers, intervention experiences and outcomes to broaden input for continuous program improvement.
描述(由申请人提供):拟议的是一个基于社区的参与性研究项目(CBPR)和改善处境不利的少数群体中高风险人群中流感免疫接种的评估。哈林社区与学术合作伙伴关系(HCAP)的董事会包括居民,社区组织,学术合作伙伴和当地卫生部门,他们每月开会以计划,进行和审查邻里评估,干预和评估活动;特定于主题的问题是通过组建干预工作组(IWG)来解决的。 HCAP委员会指出,哈林的流感免疫接种率特别低,并形成了Viva(成人的场地强化疫苗)IWG。该IWG进行了单独的飞行员,包括一项有关免疫障碍的调查,开发文化知情的干预材料,“黄色外套”外展工人的飞行员,以吸引和教育难以到达的人群以及在非传统场所提供免疫接种。该提案的目的是组装这些组成部分,以正式扩展和测试哈林社区成年人的干预措施。为了实现这些目标,HCAP Viva IWG将计划,组织和实施干预;我们的主要合作伙伴Palladia Inc提供了外展教育者和一个由120多个CBO的服务网络,以教育和动员社区进行免疫接种,并协调聚会人员与传统和新的非传统场所进行免疫接种;当地来访的护士服务已同意免费在所选场所提供护士和流感疫苗。该计划不会取代,而是通过增加更相关的教育和新的“非传统”场所来补充城市中现有的疫苗接种计划。我们预计该计划将提高总体上的免疫接种率,包括难以到达的人群。为了评估该计划,我们将比较Harlem与类似于Harlem在纽约市的社区之间的年度免疫接种率,以及通过NYC年度“社区健康调查”(CDC修改的BRFS)提供的社区数据,其中包括10,000名成人纽约市居民。我们还将在Harlem和比较社区居民之间的每年年度干预计划之前和之后进行两次横截面街道拦截调查(n = 800)。这些数据与年度CBO库存相结合,将提供障碍,干预经验和结果的度量,以扩大持续计划改进的投入。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID VLAHOV其他文献
DAVID VLAHOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID VLAHOV', 18)}}的其他基金
Harlem Community Academic Partnership: Influenza Immunizations
哈莱姆社区学术合作伙伴:流感免疫接种
- 批准号:
7493793 - 财政年份:2008
- 资助金额:
$ 8.67万 - 项目类别:
Harlem Community Academic Partnership: Influenza Immunizations
哈莱姆社区学术合作伙伴:流感免疫接种
- 批准号:
8212491 - 财政年份:2008
- 资助金额:
$ 8.67万 - 项目类别:
Harlem Community Academic Partnership: Influenza Immunizations
哈莱姆社区学术合作伙伴:流感免疫接种
- 批准号:
8289754 - 财政年份:2008
- 资助金额:
$ 8.67万 - 项目类别:
Harlem Community Academic Partnership: Influenza Immunizations
哈莱姆社区学术合作伙伴:流感免疫接种
- 批准号:
7778895 - 财政年份:2008
- 资助金额:
$ 8.67万 - 项目类别:
Heroin Cessation and Hiv Risk: A Case-Control Study
海洛因戒断和艾滋病毒风险:病例对照研究
- 批准号:
7285755 - 财政年份:2007
- 资助金额:
$ 8.67万 - 项目类别:
Heroin Cessation and Hiv Risk: A Case-Control Study
海洛因戒断和艾滋病毒风险:病例对照研究
- 批准号:
8055105 - 财政年份:2007
- 资助金额:
$ 8.67万 - 项目类别:
Heroin Cessation and Hiv Risk: A Case-Control Study
海洛因戒断和艾滋病毒风险:病例对照研究
- 批准号:
7498006 - 财政年份:2007
- 资助金额:
$ 8.67万 - 项目类别:
Heroin Cessation and Hiv Risk: A Case-Control Study
海洛因戒断和艾滋病毒风险:病例对照研究
- 批准号:
7661665 - 财政年份:2007
- 资助金额:
$ 8.67万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Applying Deep Learning for Predicting Retention in PrEP Care and Effective PrEP Use among Key Populations at Risk for HIV in Thailand
应用深度学习预测泰国主要艾滋病毒高危人群中 PrEP 护理的保留情况以及 PrEP 的有效使用
- 批准号:
10619943 - 财政年份:2023
- 资助金额:
$ 8.67万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 8.67万 - 项目类别:
Promoting linkage to PrEP after HIV self-testing through a peer-led intervention for MSM
通过同伴主导的 MSM 干预措施,促进 HIV 自我检测后与 PrEP 的联系
- 批准号:
10700283 - 财政年份:2023
- 资助金额:
$ 8.67万 - 项目类别:
Implementation of PrEP Care Among Women in Family Planning Clinics
在计划生育诊所对妇女实施 PrEP 护理
- 批准号:
10744477 - 财政年份:2023
- 资助金额:
$ 8.67万 - 项目类别:
PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study
注射毒品者的 PrEP 和 MOUD 快速获取:CHORUS 研究
- 批准号:
10682181 - 财政年份:2023
- 资助金额:
$ 8.67万 - 项目类别: